Federal prisons must keep providing hormone therapy to transgender inmates, a judge says

Jillian Sackler, a prominent philanthropist known for fiercely defending the legacy of her late husband, Arthur Sackler (whose family name is tied to both medical philanthropy and the opioid crisis), has passed away at 84. She dedicated much of her life to supporting the arts, education, and medical research while navigating the complicated reputation of the Sackler name.

Editor’s Note: This isn’t just an obituary—it’s a reflection on how legacy and philanthropy intersect with controversy. The Sackler name carries weight in both medical advancements (thanks to their donations) and the opioid epidemic (due to Purdue Pharma’s OxyContin ties). Jillian’s death invites questions about how society remembers families with complex histories, especially when they’ve contributed so much—and also caused harm. It’s a nuanced story about money, influence, and how we judge the dead.

Scientists are exploring whether mRNA technology—the same breakthrough used in COVID-19 vaccines—could be repurposed to help the body fight off HIV. Early research suggests it might train the immune system to target and eliminate the virus, offering a potential new path toward a cure or long-term treatment.

Editor’s Note: HIV has been one of medicine’s toughest challenges, with no cure yet. If mRNA can crack this puzzle, it could be a game-changer—not just for HIV but for how we tackle other stubborn viruses. It’s still early, but the idea that COVID-era science might unlock solutions for another global health crisis is pretty exciting.

A supplement once popular mainly with male bodybuilders is now being heavily marketed to women, touted as a miracle solution for antiaging, toning, and overall wellness. But here’s the catch—it’s not a magic pill. You still have to put in the work at the gym.

Editor’s Note: This story highlights how marketing trends shift to tap into new demographics—in this case, women seeking quick fixes for fitness and aging. While the supplement’s growing appeal shows changing consumer habits, the underlying message is a reminder that no product replaces effort. It’s also a peek into how industries rebrand old products for fresh audiences, sometimes blurring the line between hope and reality.

Elon Musk recently addressed reports about his ketamine use, clarifying that while he's used it therapeutically in the past, he denies frequent or recreational use. The discussion resurfaced amid broader debates about ketamine’s medical applications versus its potential for misuse.

Editor’s Note: Musk’s comments throw a spotlight on ketamine’s dual reputation—as a promising treatment for depression and PTSD, but also a drug with abuse risks. His high-profile admission keeps the conversation going about how society views mental health treatments, celebrity transparency, and the fine line between medicine and recreation.

A Michigan woman with sickle cell disease is sounding the alarm after the CDC quietly disbanded its team researching safe birth control options for chronic conditions. She believes this decision could literally put her life—and others like her—in danger. Public health experts are worried too, saying doctors may now lack crucial guidance, leaving vulnerable women without proper care.

Editor’s Note: This isn't just bureaucratic shuffling—real lives are on the line. Sickle cell disease already complicates pregnancy and birth control choices, and without specialized research, doctors are left guessing. It’s a stark reminder of how policy shifts can ripple through people’s lives in deeply personal, even dangerous, ways.